+44-1518081136Articles in press and Articles in process
Perspective P.1-1
Addressing drug shortages: Strategies and challenges in pharmaceutical policy implementation.
Author(s): John Woosley*
Perspective P.1-1
Analyzing the economic implications of orphan drug policies on pharmaceutical manufacturers and patients.
Author(s): Peter Kelle*
Perspective P.1-1
Assessing the impact of generic drug substitution policies on patient outcomes: A comparative analysis.
Author(s): Janey Johnson*
Perspective P.1-1
Evaluating the effectiveness of pharmaceutical price controls in enhancing access to essential medications.
Author(s): Dana Goldman*
Perspective P.1-1
Exploring the influence of intellectual property rights on access to medicines: A global perspective.
Author(s): Darius Lakdawalla*
Perspective P.1-1
Patient-centered approaches to pharmaceutical policy: Bridging the gap between healthcare providers and regulators.
Author(s): Denis Horgan*
Perspective P.1-1
Pharmaceutical policy and drug safety: An in-depth examination of pharmacovigilance practices.
Author(s): Matthew Epperson*
Perspective P.1-2
Pharmaceutical policy and the rise of biosimilars: Lessons learned and future directions.
Author(s): Dinar Kale*
Perspective P.1-1
The impact of health insurance systems on medication adherence: A crossnational study.
Author(s): Mahboub Bassam*
Perspective P.1-2
The role of health technology assessment in shaping pharmaceutical policy: Case studies from global health systems.
Author(s): Lara Gautier*
Perspective P.1-2
Tackling global health challenges: exploring clinical research's impact worldwide.
Author(s): Lisa Rodriguez
DOI: 10.35841/aajcrp-6.3.153
Full Text PDFReview Article P.1-4
A review on COVID-19: Pathogenesis, control and medicine.
Author(s): Maheep Kumar*